期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Tet methylcytosine dioxygenase 2(TET2)deficiency elicits EGFR-TKI(tyrosine kinase inhibitors)resistance in non-small cell lung cancer
1
作者 Jian Zhang Kejia Zhao +16 位作者 Wenjing Zhou Ran Kang Shiyou Wei Yueli Shu Cheng Yu Yin Ku Yonghong Mao Hao Luo Jugin Yang Jiandong Mei Qiang Pu Senyi Deng Zhengyu Zha Gang Yuan shensi shen Yaohui Chen Lunxu Liu 《Signal Transduction and Targeted Therapy》 SCIE CSCD 2024年第4期1706-1720,共15页
Despite epidermal growth factor receptor(EGFR)tyrosine kinase inhibitors(TKl)have shown remarkable efficacy in patients with EGFR-mutant non-small cell lung cancer(NSCLC),acquired resistance inevitably develops,limiti... Despite epidermal growth factor receptor(EGFR)tyrosine kinase inhibitors(TKl)have shown remarkable efficacy in patients with EGFR-mutant non-small cell lung cancer(NSCLC),acquired resistance inevitably develops,limiting clinical efficacy.We found that TET2 was poly-ubiquitinated by E3 ligase CUL7^(FBXW11) and degraded in EGFR-TKI resistant NSCLC ells.Genetic perturbationof TET2 rendered parental cells more tolerant to TKI treatment.TET2 was stabilized by MEK1 phosphorylation at Ser 1107,while MEK1 inactivation promoted its proteasome degradation by enhancing the recruitment of CUL7^(FBXW11),Loss of TET2 resulted in the upregulation of TNF/NF-kB signaling that confers the EGFR-TKI resistance.Genetic or pharmacological inhibition of NF-kB attenuate the TKI resistance both in vitro and in vivo.Our findings exemplified how a cell growth controlling kinase MEK1 leveraged the epigenetic homeostasis by regulating TET2,and demonstrated an alternative path of non-mutational acquired EGFR-TKI resistance modulated by TET2 deficiency.Therefore,combined strategy exploiting EGFR-TKI and inhibitors of TET2/NF-κB axis holds therapeutic potential for treating NSCLC patients who suffered from this resistance. 展开更多
关键词 TET2 TKI RESISTANCE
原文传递
Engineering a Circular Riboregulator in Escherichia coli
2
作者 William Rostain shensi shen +2 位作者 Teresa Cordero Guillermo Rodrigo Alfonso Jaramillo 《BioDesign Research》 2020年第1期9-17,共9页
RNAs of different shapes and sizes,natural or synthetic,can regulate gene expression in prokaryotes and eukaryotes.Circular RNAs have recently appeared to be more widespread than previously thought,but their role in p... RNAs of different shapes and sizes,natural or synthetic,can regulate gene expression in prokaryotes and eukaryotes.Circular RNAs have recently appeared to be more widespread than previously thought,but their role in prokaryotes remains elusive.Here,by inserting a riboregulatory sequence within a group I permuted intron-exon ribozyme,we created a small noncoding RNA that self-splices to produce a circular riboregulator in Escherichia coli.We showed that the resulting riboregulator can trans-activate gene expression by interacting with a cis-repressed messenger RNA.We characterized the system with a fluorescent reporter and with an antibiotic resistance marker,and we modeled this novel posttranscriptional mechanism.This first reported example of a circular RNA regulating gene expression in E.coli adds to an increasing repertoire of RNA synthetic biology parts,and it highlights that topological molecules can play a role in the case of prokaryotic regulation. 展开更多
关键词 MECHANISM CIRCULAR SIZES
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部